ABBV (AbbVie Inc.) is set to announce its Q2'26 results on July 31, before the market opens. The earnings are expected to be disclosed at 9:30 AM ET (1:30 PM UTC).
For Q2'26, revenue estimate is 16.79 billion USD with EPS (earnings per share) anticipated at 3.60 USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported15.42 B15.78 B16.62 B15.00 B— | Revenue Estimate15.03 B15.59 B16.41 B14.72 B16.79 B | Revenue Surprise+2.62%+1.22%+1.25%+1.93% | EPS Reported2.971.862.712.65 | EPS Estimate2.881.772.652.593.60 | EPS Surprise+3.12%+5.34%+2.15%+2.25% |